What Is Mass Spectrometry? Confirming Peptide Identity and Mass

Published October 2026 · Patriot Labs Research Team · ~18 min read

The short answer

Mass spectrometry is an analytical technique that weighs molecules. It turns a peptide into gas-phase ions, sorts those ions by their mass-to-charge ratio, and reports where they land, so the measured mass can be compared with the mass calculated from the intended sequence. When the two match within a small tolerance, that is strong evidence the molecule in the sample is the one on the label.

A mass spectrometer does three things in sequence: it ionizes the sample, pushing molecules into the gas phase as charged ions; it separates those ions in electric or magnetic fields according to their mass-to-charge ratio; and it detects them, counting how many land at each value. The output is a spectrum — a plot of signal against mass-to-charge — from which the molecule’s mass is read.

For research peptides, mass spectrometry answers the identity question that a purity number alone cannot: not “how much of the powder is peptide,” but “is this the right molecule at all.” It is one of the two analyses that normally appear on a peptide’s certificate of analysis, the other being reversed-phase HPLC for purity. The rest of this guide explains how the measurement works, what the numbers on a report mean, and — as important — what a mass match does and does not prove.

What a mass spectrometer actually measures

A mass spectrometer does not measure mass directly; it measures the mass-to-charge ratio, written m/z, of ions. Mass has to be worked out from that ratio once the charge is known.

Every separation inside the instrument — whether by time of flight, by a radiofrequency field, or by an orbital frequency — acts on the ratio of an ion’s mass to its number of charges, not on mass alone. An ion carrying one charge and an ion of twice the mass carrying two charges share the same m/z and, other things being equal, behave the same way. That is why a spectrum’s horizontal axis is labelled m/z and why interpreting it begins with establishing how many charges each peak carries.

The quantities a report may state follow from this. The nominal mass uses whole-number isotope masses (hydrogen 1, carbon 12, nitrogen 14, oxygen 16) and ignores the small deviations from whole numbers. The monoisotopic mass uses the exact mass of the most abundant isotope of each element — carbon-12 defined as exactly 12.000000, hydrogen-1 as 1.007825, oxygen-16 as 15.994915. The average mass uses each element’s mass averaged over its natural isotope abundances, so carbon is taken as 12.011 rather than 12.^[6] A single peptide therefore has more than one “mass” depending on which convention is used, and a report that gives a number without saying which can be read incorrectly. The certificate-of-analysis guide shows where these numbers sit on a real report.

Measuring the mass of something as small as a peptide is a feat worth pausing on. A molecule weighing a thousand daltons has an absolute mass of roughly 10⁻²¹ grams; it cannot be placed on a balance. Mass spectrometry reaches it indirectly, by giving the molecule a charge and watching how that charge responds to a known field. The whole history of the technique, told next, is the history of learning to do that to molecules that are large, fragile and unwilling to enter the gas phase.

Getting a peptide into the instrument: ESI and MALDI

The hardest part of weighing a peptide is getting an intact, charged peptide into the gas phase without tearing it apart. Two “soft” ionization methods solved that problem in the late 1980s — electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI) — and their inventors shared the 2002 Nobel Prize in Chemistry.^[1]

Mass spectrometry itself is old: J. J. Thomson analysed small ions in the first years of the twentieth century, and for decades the technique was limited to molecules small and robust enough to be vaporised by heat. Large biomolecules simply decomposed before they could be ionized. An early hint of a way around this came in 1968, when Malcolm Dole proposed generating gas-phase “macroions” from a fine electrically charged spray — the conceptual seed of electrospray.^[3] The practical breakthroughs arrived twenty years later.

Electrospray ionization (ESI)

In electrospray, a solution of the peptide is pushed through a fine needle held at a high voltage. The field disperses the liquid into a mist of highly charged droplets; as solvent evaporates, the droplets shrink and divide until bare, charged peptide ions are left in the gas phase. John Fenn’s group reported in 1988–1989 that electrospray could do this for large biomolecules, including intact proteins.^[2]

Electrospray’s defining feature is that it produces multiply charged ions. A peptide picks up protons at its basic sites, so a single compound appears not as one peak but as a series of them, each differing by one charge. An n-fold protonated peptide of neutral mass M appears at m/z = (M + n × 1.00728) / n; peptides commonly show ions from (M+2H)²⁺ to (M+5H)⁵⁺, landing mostly between m/z 300 and 1500.^[6] This looks complicated but is useful twice over: the charges pull large molecules down into a modest m/z window that ordinary analyzers can reach, and the regular spacing of the peaks lets the software calculate the charge and, from it, the true mass. Because the sample enters as a liquid, electrospray couples naturally to liquid chromatography, giving the LC-MS instruments that dominate peptide analysis; a refinement, nano-electrospray, lowered the sample demand into the femtomole range.^[9]

Matrix-assisted laser desorption/ionization (MALDI)

MALDI takes a different route. The peptide is mixed with a large excess of a small, strongly UV-absorbing organic compound — the matrix — and the mixture is dried to a crystalline spot on a metal target. A pulsed laser strikes the spot; the matrix absorbs the energy, vaporises, and carries the peptide with it into the gas phase, transferring a proton in the process. The term was coined in 1985 by Karas, Hillenkamp and colleagues, and in 1988 Karas and Hillenkamp reported laser desorption of proteins above 10,000 daltons.^[4] In the same period Koichi Tanaka showed that a laser method could ionize proteins of tens of thousands of daltons intact, work for which he shared the Nobel Prize.^[1][5]

The matrix sits in a roughly thousand- to million-fold molar excess and does three jobs: it absorbs the laser light, it holds the peptide molecules apart so they do not clump, and it supplies the proton that charges them.^[6] Common matrices are sinapinic acid, α-cyano-4-hydroxycinnamic acid and 2,5-dihydroxybenzoic acid.^[14] Unlike electrospray, MALDI produces mainly singly charged ions — chiefly (M+H)⁺ — which makes its spectra simpler to read, one peak per species. It is almost always paired with a time-of-flight analyzer, giving the MALDI-TOF instruments used for the peptide mass fingerprinting that identifies proteins from the set of fragment masses produced by enzymatic digestion.^[14]

The analyzers that sort the ions

Once ions exist in the gas phase, a mass analyzer separates them by m/z. Several designs do this on different physical principles, and they trade speed, mass range, resolution and cost against one another.

The time-of-flight (TOF) analyzer is the most intuitive: a fixed voltage gives every ion the same kinetic energy, so lighter and more highly charged ions fly down a vacuum tube faster and arrive first, and the flight time converts to m/z. TOF has a very large mass range and suits the pulsed nature of a MALDI laser; a reflectron, which turns the ions around in an electric mirror, sharpens the measurement considerably.^[14] The quadrupole uses four parallel rods carrying combined radiofrequency and direct-current voltages to let only one m/z through at a time; it is robust, compact and the workhorse of routine LC-MS. An ion trap stores ions in a three-dimensional field and ejects them by m/z, and is well suited to the repeated fragmentation steps of tandem mass spectrometry.

Two designs reach far higher performance. Fourier-transform ion cyclotron resonance (FT-ICR), introduced by Comisarow and Marshall in 1974, measures the frequency at which ions orbit in a strong magnetic field; because frequency can be measured extremely precisely, FT-ICR delivers the highest resolution available.^[8] The Orbitrap, introduced by Alexander Makarov in 2000, traps ions in orbit around a central spindle electrode and reads their oscillation frequency, giving very high resolution and mass accuracy from a comparatively compact instrument.^[7] High-resolution analyzers of this kind underpin modern mass-spectrometry-based proteomics, in which thousands of peptides are identified from a single sample.^[12]

Monoisotopic mass, average mass and the isotope pattern

A pure peptide does not give a single sharp mass but a small cluster of peaks spaced about one dalton apart, because the elements it is built from occur as mixtures of isotopes. Which peak counts as “the mass” depends on the size of the molecule and the resolution of the instrument.

The cluster exists because about 1.1% of carbon atoms are carbon-13 rather than carbon-12, with smaller contributions from the heavy isotopes of hydrogen, nitrogen, oxygen and sulfur. A peptide with dozens of carbon atoms will, as a population, contain molecules with zero, one, two or more heavy isotopes, and each shows up one dalton higher than the last. The monoisotopic peak is the one in which every atom is the lightest isotope; for small and mid-sized peptides an instrument can resolve it cleanly, and it is the value normally quoted because it is sharp and exactly calculable.^[6]

As molecules get larger the cluster broadens and the all-light-isotope species becomes vanishingly rare, so for large proteins the average mass — the intensity-weighted centre of the envelope — is used instead. The gap between the two conventions grows with size: for a protein such as apomyoglobin the monoisotopic mass (about 16,941 daltons) sits roughly 10.5 daltons below the average mass (about 16,951 daltons).^[6] For a typical research peptide the difference is under a dalton, but it is still the reason a reported mass must say which convention it uses before an observed and a theoretical value can be compared.

With electrospray there is an extra step. Because the peptide appears as a ladder of multiply charged peaks, software reads the spacing between adjacent charge states to solve for the charge z and then back-calculates the neutral mass — a routine called charge deconvolution. The arithmetic is exact: from two neighbouring peaks the charge follows from their separation, and the mass follows from the charge.^[6] A clean deconvoluted mass from a series of charge states is one of the more reliable numbers in peptide analysis.

Resolution and mass accuracy

Two different qualities decide how trustworthy a mass measurement is: resolution, the ability to separate two peaks that are close together, and mass accuracy, how close the measured value is to the true one. They are related but not the same.

Resolution is defined as R = m/Δm, where Δm is usually the width of a peak at half its height; a peak at m/z 1000 that is 0.5 units wide corresponds to a resolution of 2000.^[6] Higher resolution lets an instrument split the one-dalton isotope spacing — needed to count charges on a peptide — and distinguish species that differ only slightly in mass. Mass accuracy is reported in parts per million (ppm): a measurement good to 10 ppm at m/z 1000 is accurate to about 0.01 units. Accuracy depends not only on resolution but on careful calibration against standards of known mass and on reproducible peak shapes.^[6]

The stakes are concrete. The residues lysine and glutamine differ in mass by only 0.0364 daltons; telling them apart at m/z 1000 needs accuracy of roughly 36 ppm, and at m/z 10,000 roughly 3.6 ppm.^[6] This is why a high-resolution analyzer such as an Orbitrap or an FT-ICR adds confidence: it does not merely place a peak, it can resolve near-identical masses that a unit-resolution instrument would merge. For routine identity confirmation, however, a well-calibrated instrument of modest resolution is usually sufficient, because the question is whether the observed mass matches a single expected value, not whether two unknowns can be separated.

How a measured mass confirms identity

Identity confirmation by mass spectrometry is a comparison: the mass observed for the sample is set against the mass calculated from the molecular formula of the intended sequence, and a match within a stated tolerance supports the claim that the sample is that molecule. It is the “identity” line on a peptide certificate of analysis.

The theoretical mass is not guessed; it is summed from the sequence. Each amino acid contributes a known residue mass, a water molecule is added for the two chain ends, and any modification — an N-terminal acetyl group, a C-terminal amide, a disulfide bond — shifts the total by its own characteristic amount. Many modifications have signature mass changes that a spectrum reveals directly: amidation lowers the mass by about one dalton, acetylation adds about 42, and a single disulfide bond removes about two hydrogen atoms. The companion guides on amidation, acetylation and the disulfide bond describe these edits in detail; mass spectrometry is how each is confirmed on the bench.

One subtlety belongs on the identity question: the salt form. A synthetic peptide is usually isolated as a salt — commonly trifluoroacetate or acetate — but the counterion is not covalently attached, so the mass measured for the peptide ion reflects the peptide itself, not the salt weighed with it. That is why mass spectrometry speaks to the identity of the molecule while a separate measurement is needed to account for counterion and water; the counterion guide explains the distinction. For reference, Patriot Labs has every batch tested by an independent US laboratory by HPLC and mass spectrometry, and publishes the certificate of analysis on each product page — the identity figure described here is the mass-spectrometry half of that document.

A mass match is powerful but not absolute. Because the measurement returns a mass, any two molecules that happen to share that mass are indistinguishable on mass alone — a sequence written in a different order, or a pair of residues swapped for another pair of equal total mass, can give the same number. Resolving those cases needs the molecule to be broken into pieces and the pieces weighed, which is the subject of the next section.

Reading the sequence: tandem mass spectrometry

Tandem mass spectrometry, or MS/MS, goes beyond the whole-molecule mass by selecting one peptide ion, breaking it into fragments, and weighing the fragments — the differences between them spell out the sequence. It is how mass spectrometry moves from “the mass is right” to “the order of residues is right.”

The usual way to break the ion is collision-induced dissociation (CID), in which the selected ion is accelerated into an inert gas. Peptides fragment preferentially at the amide bond of the backbone, producing two complementary families of fragment ions: b-ions, which keep the N-terminal end, and y-ions, which keep the C-terminal end.^[15] The naming convention — a, b and c for N-terminal fragments and x, y and z for C-terminal fragments — was proposed by Roepstorff and Fohlman in 1984 and refined by Biemann, whose version became standard.^[10][11]

The sequence is read from the spacing. Within one series — all the y-ions, say — consecutive fragments differ by exactly one residue’s mass, so stepping along the ladder and reading off each gap names the residues in order. Because the b- and y-series run in opposite directions along the same backbone, they cross-check each other, and a complementary b/y pair sums to the peptide mass plus about two daltons.^[15] Alternative fragmentation methods, such as electron-transfer and electron-capture dissociation, cleave a different backbone bond to give mainly c- and z-type ions and are often better for peptides carrying fragile modifications. This fragment-ladder reading is the basis both of de novo sequencing, which reconstructs an unknown sequence from the spectrum alone, and of database searching, which matches a spectrum to a predicted one — the engine of modern proteomics.^[12]

Identity is not purity: mass spectrometry and HPLC together

Mass spectrometry and reversed-phase HPLC answer two different questions, and a certificate of analysis normally carries both because neither substitutes for the other. Mass spectrometry asks what the molecule is; HPLC purity asks how much of the sample is that molecule rather than related impurities.

HPLC separates a sample’s components in time and measures the area under each peak, expressing the main component as a percentage of the total — the purity figure. It is good at saying that one species dominates, but on its own it does not prove which species that is. Mass spectrometry supplies the missing half: it confirms the dominant peak is the intended peptide and can identify what the minor peaks are. Run together, as in LC-MS, the two become one analysis in which every chromatographic peak also gets a mass, so impurities can be both quantified and identified.

Neither measurement, though, tells the whole story of a vial. HPLC purity is a percentage of peptide-related material and does not count the water and counterion weighed with the powder; that is the separate question of net peptide content, measured by amino acid analysis or nitrogen determination. The purity-grades guide explains what a percentage does and does not mean, and the COA guide shows how identity, purity, content, counterion and water sit together on one report. The useful mental model is that mass spectrometry establishes identity, HPLC establishes purity, and content analysis establishes quantity — three distinct facts, no one of which implies the others.

What mass spectrometry does not establish

Mass spectrometry is an identity and structure tool, not a verdict on everything about a sample. Several limits are worth stating plainly.

• A mass match is not a sequence proof. Molecules of equal mass are indistinguishable on intact-mass data alone; confirming the order of residues requires tandem MS, and even that has blind spots, such as the near-identical masses of leucine and isoleucine.
• It does not measure how much peptide is present. Signal intensity depends heavily on how readily a given molecule ionizes, so a mass spectrum is not a reliable measure of quantity or purity; those come from HPLC and content analysis.
• Sample handling shapes the spectrum. Sodium and potassium adducts, oxidation and incomplete desalting can add or shift peaks, and a matrix or solvent choice influences what is seen. A spectrum is read in the light of how the sample was prepared.
• It says nothing about biological activity. A correct mass and sequence describe the molecule, not what it does; this guide makes no claim about any effect of any compound in a person or an animal.
• It describes the analysis, not any particular vial. The methods here are general. What a specific batch contains is established only by that batch’s own lot-specific certificate of analysis.

Frequently asked questions

What is mass spectrometry?

Mass spectrometry is an analytical technique that weighs molecules by turning them into gas-phase ions, sorting those ions by their mass-to-charge ratio in electric or magnetic fields, and detecting where they land. The result is a spectrum from which a molecule’s mass is read. For peptides it is used mainly to confirm identity — that the molecule present is the one intended.

How does mass spectrometry confirm a peptide’s identity?

It measures the peptide’s mass and compares it with the mass calculated from the intended amino acid sequence. Each residue contributes a known mass, water is added for the chain ends, and modifications shift the total by characteristic amounts. When the observed mass matches the theoretical value within a small tolerance, that supports the identity claim. Tandem mass spectrometry can go further and read the sequence itself.

What is the mass-to-charge ratio (m/z)?

The mass-to-charge ratio, written m/z, is an ion’s mass divided by the number of charges it carries. A mass spectrometer separates ions by this ratio rather than by mass alone, so the charge must be known before a mass can be worked out. Multiply charged ions, common in electrospray, appear at lower m/z than their true mass.

What is the difference between monoisotopic mass and average mass?

Monoisotopic mass uses the exact mass of the most abundant isotope of each element (carbon-12 as exactly 12, and so on), giving a single sharp value used for small and mid-sized peptides. Average mass uses each element’s mass averaged over its natural isotopes (carbon as 12.011), and is used for large proteins where the isotope cluster blurs. The gap between them grows with molecular size.

What is the difference between ESI and MALDI?

Both are soft ionization methods that put intact peptides into the gas phase. Electrospray (ESI) sprays a liquid sample through a charged needle and produces multiply charged ions, so it couples to liquid chromatography and dominates LC-MS. MALDI mixes the peptide with a UV-absorbing matrix and uses a laser pulse, producing mainly singly charged ions and simpler spectra, and is usually paired with a time-of-flight analyzer.

Why does electrospray ionization produce multiply charged ions?

In electrospray a peptide picks up a proton at each of its basic sites as it leaves the charged droplet, so one molecule can carry several charges and appears as a series of peaks differing by one charge each. This pulls large molecules into a lower mass-to-charge window that ordinary analyzers can reach, and the regular spacing of the peaks lets software calculate the charge and the true mass.

Can mass spectrometry prove a peptide is pure?

No. Mass spectrometry confirms identity — what the molecule is — but ion signal depends strongly on how readily each species ionizes, so it is not a reliable measure of purity or quantity. Purity is measured by reversed-phase HPLC as a percentage of peak area, and how much of the powder is peptide is a separate question of net peptide content. The three analyses are complementary.

What are b-ions and y-ions in peptide sequencing?

When a peptide ion is fragmented in tandem mass spectrometry, it breaks mostly at the backbone amide bonds into two complementary families: b-ions keep the N-terminal end and y-ions keep the C-terminal end. Consecutive ions in one family differ by exactly one residue’s mass, so reading the spacing along the ladder spells out the sequence. The naming follows the Roepstorff–Fohlman scheme as refined by Biemann.

References

1. The Nobel Prize in Chemistry 2002 — John B. Fenn and Koichi Tanaka “for their development of soft desorption ionisation methods for mass spectrometric analyses of biological macromolecules,” shared with Kurt Wüthrich. NobelPrize.org. https://www.nobelprize.org/prizes/chemistry/2002/
2. Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., & Whitehouse, C. M. (1989). Electrospray ionization for mass spectrometry of large biomolecules. Science, 246(4926), 64–71. doi:10.1126/science.2675315
3. Dole, M., Mack, L. L., Hines, R. L., Mobley, R. C., Ferguson, L. D., & Alice, M. B. (1968). Molecular beams of macroions. The Journal of Chemical Physics, 49(5), 2240–2249. doi:10.1063/1.1670391
4. Karas, M., & Hillenkamp, F. (1988). Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Analytical Chemistry, 60(20), 2299–2301. doi:10.1021/ac00171a028
5. Tanaka, K., Waki, H., Ido, Y., Akita, S., Yoshida, Y., Yoshida, T., & Matsuo, T. (1988). Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry, 2(8), 151–153. doi:10.1002/rcm.1290020802
6. Strupat, K. (2005). Molecular weight determination of peptides and proteins by ESI and MALDI. Methods in Enzymology, 405, 1–36. https://msf.ucsf.edu/documents/Strupat_MethodsEnzymology_v405.pdf
7. Makarov, A. (2000). Electrostatic axially harmonic orbital trapping: a high-performance technique of mass analysis. Analytical Chemistry, 72(6), 1156–1162. doi:10.1021/ac991131p
8. Comisarow, M. B., & Marshall, A. G. (1974). Fourier transform ion cyclotron resonance spectroscopy. Chemical Physics Letters, 25(2), 282–283. doi:10.1016/0009-2614(74)89137-2
9. Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T., & Mann, M. (1996). Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature, 379(6564), 466–469. doi:10.1038/379466a0
10. Roepstorff, P., & Fohlman, J. (1984). Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomedical Mass Spectrometry, 11(11), 601. doi:10.1002/bms.1200111109
11. Biemann, K. (1988). Contributions of mass spectrometry to peptide and protein structure. Biomedical and Environmental Mass Spectrometry, 16(1–12), 99–111. doi:10.1002/bms.1200160119
12. Aebersold, R., & Mann, M. (2003). Mass spectrometry-based proteomics. Nature, 422(6928), 198–207. doi:10.1038/nature01511
13. Merrifield, R. B. (1963). Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society, 85(14), 2149–2154. doi:10.1021/ja00897a025
14. Matrix-assisted laser desorption/ionization. Wikipedia. https://en.wikipedia.org/wiki/Matrix-assisted_laser_desorption/ionization
15. De novo peptide sequencing. Wikipedia. https://en.wikipedia.org/wiki/De_novo_peptide_sequencing

For the documents that carry these results, see Understanding Peptide COA Testing; for the purity number mass spectrometry does not provide, Peptide Purity Grades Explained and What Is Net Peptide Content; for how the molecule being measured is built, How Peptides Are Made; and for why the counterion is not part of the measured peptide mass, TFA vs Acetate in Peptides.

All Patriot Labs products are sold strictly for in-vitro research and laboratory use only. Not for human or veterinary consumption. This guide is educational and explains an analytical technique in general terms; it is not medical advice, does not describe how to use any product, and makes no claim about the properties or effects of any specific compound.